Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction
2006; Massachusetts Medical Society; Volume: 355; Issue: 12 Linguagem: Inglês
10.1056/nejmoa055706
ISSN1533-4406
AutoresKetil Lunde, Svein Solheim, Svend Aakhus, Harald Arnesen, Michael Abdelnoor, Torstein Egeland, Knut Endresen, Arnfinn Ilebekk, Arild Mangschau, Jan Gunnar Fjeld, H.-J. Smith, Eli Taraldsrud, Haakon K. Grøgaard, Reidar Bjørnerheim, Magne Brekke, Carl Müller, Einar Hopp, Asgrimur Ragnarsson, Jan E. Brinchmann, Kolbjørn Forfang,
Tópico(s)Tissue Engineering and Regenerative Medicine
ResumoPrevious studies have shown improvement in left ventricular function after intracoronary injection of autologous cells derived from bone marrow (BMC) in the acute phase of myocardial infarction. We designed a randomized, controlled trial to further investigate the effects of this treatment.
Referência(s)